3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Motor Activity
3
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Obesity
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
fludarabine phosphate
22
Cyclophosphamide
22
Peripheral Blood Stem Cell Transplantation
21
Tacrolimus
15
Busulfan
14
Cyclosporine
13
Whole-Body Irradiation
12
Mycophenolic Acid
12
Methotrexate
12
Antilymphocyte Serum
10
Filgrastim
7
Etoposide
6
Radiotherapy
5
Methylprednisolone
5
Decitabine
5
Carboplatin
5
ruxolitinib
4
fludarabine
4
Melphalan
4
Flow Cytometry
4
Topotecan
3
Thiotepa
3
Cytogenetic Analysis
3
Cytarabine
3
veliparib
2
merphos
2
liposomal amphotericin B
2
aldesleukin
2
Watchful Waiting
2
Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombocythemia, Essential
×
Resistance Training
×
Other hematologic neoplasm
×
Clear all
NCT07518940
2026-04-09
ENERGIA
University of Turin, Italy
Phase NA
Not yet recruiting
25 enrolled